Clinical Trial Update: Buprenorphine Versus Methadone Maintenance in Hepatitis C Patients Receiving Peg-Intron and Rebetol (Study P04279)(TERMINATED) [Phase 4]

View source ↗

Summary

Phase 4 trial comparing buprenorphine and methadone maintenance in chronic hepatitis C patients treated with Peg-Intron and Rebetol has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Methadone (methadone)
• PegIntron (pegylated interferon alfa-2b)
• Rebetol (ribavirin)
• buprenorphine (buprenorphine)

Snippet

Sponsor: Indivior Inc. | Conditions: Hepatitis C, Chronic | Phase 4 | Status: TERMINATED